NCT06486129

Brief Summary

Chronic effects of noninvasive ventilation on myocardial function in patients with obesity hypoventilation syndrome (OHS) are scarcely understood. The aim of the present study was to evaluate the long-term effects of volume-targeted bilevel-positive airway pressure ventilation (BiPAP) on cardiac parameters and myocardial biomarkers in patients with OHS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2016

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2020

Completed
4.4 years until next milestone

First Submitted

Initial submission to the registry

June 20, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 3, 2024

Completed
Last Updated

July 3, 2024

Status Verified

June 1, 2024

Enrollment Period

3.7 years

First QC Date

June 20, 2024

Last Update Submit

June 26, 2024

Conditions

Keywords

Respiratory FailureObesity Hypoventilation SyndromeObstructive Sleep ApneaCardiac Outputstroke volume

Outcome Measures

Primary Outcomes (1)

  • Impedance cardiography measured cardiac output

    Impedance cardiography measured cardiac output before and after effective treatment of respiratory failure

    12 months

Secondary Outcomes (1)

  • Impedance cardiography measured stroke volume

    12 months

Study Arms (1)

Obesity hypoventilation syndrome patients treated with BPAP (NIV) therapy

EXPERIMENTAL

Clinically stable patients with OHS and severe hypercapnia during the daytime, referred to the tertiary clinic for the initiation of long-term NIV to alleviate chronic respiratory failure were consecutively enrolled to the study

Procedure: Noninvasive ventilation volume targetted

Interventions

he aim of the present study was to evaluate the long-term effects of volume-targeted bilevel-positive airway pressure ventilation (BiPAP) on cardiac parameters and myocardial biomarkers in patients with OHS

Obesity hypoventilation syndrome patients treated with BPAP (NIV) therapy

Eligibility Criteria

Age35 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Clinically stable patients with OHS and chronic severe hypercapnia

You may not qualify if:

  • inability to provide written informed consent
  • neuromuscular diseases
  • chest wall diseases
  • metabolic diseases
  • acute respiratory tract infection
  • chronic obstructive pulmonary disease (COPD)
  • systolic LV failure as evidenced by LV ejection fraction\<45% on echocardiography

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of respiratory medicine and tuberculosis, Pavol Jozef Safarik University, Medical Faculty and L. Pasteur University Hospital In Kosice

Košice, 04190, Slovakia

Location

Related Publications (1)

  • Pobeha P, Paranicova I, Trojova I, Tkacova R, Joppa P. Acute hemodynamic effects of non-invasive ventilation in patients with obesity hypoventilation syndrome. Bratisl Lek Listy. 2021;122(4):248-250. doi: 10.4149/BLL_2021_040.

    PMID: 33729816BACKGROUND

MeSH Terms

Conditions

Obesity Hypoventilation SyndromeSleep Apnea, ObstructiveCardiac Output, LowRespiratory Insufficiency

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesHypoventilationSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesHeart DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Clinically stable patients with OHS and severe hypercapnia during the daytime, referred to the tertiary clinic for the initiation of long-term NIV to alleviate chronic respiratory failure were consecutively enrolled to the study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pavol Pobeha, MD, PhD (Principal investigator)

Study Record Dates

First Submitted

June 20, 2024

First Posted

July 3, 2024

Study Start

March 1, 2016

Primary Completion

November 15, 2019

Study Completion

January 15, 2020

Last Updated

July 3, 2024

Record last verified: 2024-06

Locations